The invention relates to nanoparticles (NPs) comprising a metal alloy and a biocompatible organic stabilizer, useful in the diagnosis and therapy of pathological conditions such as cancer. The alloy NPs possess the characteristics required to be employed as contrast agents for some diagnostic techniques based on the acquisition of three-dimensional images of the human body, such as magnetic resonance imaging (MRI) and X-ray computed tomography (CT). The same alloy NPs can be employed also as sensitizers for some radiotherapy techniques such as radiotherapy by X-rays (XRT) or boron neutron capture (BNCT). In some of the embodiments of the invention, all these characteristics can coexist in the same metal NP, allowing imaging guided radiotherapy, where both imaging and/or therapy applications can be achieved simultaneously.
Importantly, the composition of the alloy NPs is selected such that they show biocompatibility and spontaneous degradation over time in the body, allowing enhanced NPs clearance compared to single-element (monomodal) nanomedicine agents. The nanoparticles are synthesized by a one-step, low-cost and green process.

TRL (Technology Readiness Level)

TRL 3 / 9







Download the brochure

  • miRNAs as diagnostic and prognostic biomarkers of oral squamous cell carcinoma

    In the last decades, the incidence of oral squamous cell carcinoma (OSCC) has been constantly increasing, yet the survival outcomes have remained essentially unchanged. This, in part, is due to a lack of efficient, non-complex and rapid diagnostic and prognostic[...]

  • Device for visualization of the anus during standard colonoscopy

    Colonoscopy with a flexible endoscope is a fundamental exam for cancer screening, it allows early diagnosis of colon and rectal cancers. Over 16.6 million colonoscopies are performed annually in United States. In the prior art, during colonoscopy the visualization of[...]

  • Matrices for in vitro tumor tissues allow to test antineoplastic drugs and protocols

    Disclosed is a 3D matrices for in vitro growth of tumor tissues. Need to prune the system variables using faster and cheaper in vitro assays in order to design the in vivo experimentation on a smaller number of animals, obtaining[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation